Market Analysis and Insights: Global Autoimmune Disease Therapeutics Market
The research report studies the Autoimmune Disease Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Autoimmune Disease Therapeutics market size is projected to reach US$ 119350 million by 2027, from US$ 98160 million in 2020, at a CAGR of 2.4% during 2021-2027.
Global Autoimmune Disease Therapeutics Scope and Segment
The global Autoimmune Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Others
by Application, this report covers the following segments
Hospitals
Clinics
Independent Pharmacies
Others
Global Autoimmune Disease Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Autoimmune Disease Therapeutics key players in this market include:
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer
F. Hoffmann-La Roche
Eli Lilly and Company
The research report studies the Autoimmune Disease Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Autoimmune Disease Therapeutics market size is projected to reach US$ 119350 million by 2027, from US$ 98160 million in 2020, at a CAGR of 2.4% during 2021-2027.
Global Autoimmune Disease Therapeutics Scope and Segment
The global Autoimmune Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Others
by Application, this report covers the following segments
Hospitals
Clinics
Independent Pharmacies
Others
Global Autoimmune Disease Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Autoimmune Disease Therapeutics key players in this market include:
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer
F. Hoffmann-La Roche
Eli Lilly and Company
1 Market Overview of Autoimmune Disease Therapeutics
1.1 Autoimmune Disease Therapeutics Market Overview
1.1.1 Autoimmune Disease Therapeutics Product Scope
1.1.2 Autoimmune Disease Therapeutics Market Status and Outlook
1.2 Global Autoimmune Disease Therapeutics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Autoimmune Disease Therapeutics Market Size by Region (2016-2027)
1.4 Global Autoimmune Disease Therapeutics Historic Market Size by Region (2016-2021)
1.5 Global Autoimmune Disease Therapeutics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.1 North America Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.2 Europe Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.4 Latin America Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.5 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2016-2027)
2 Autoimmune Disease Therapeutics Market Overview by Type
2.1 Global Autoimmune Disease Therapeutics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2016-2021)
2.3 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2022-2027)
2.4 Immunosuppressants
2.5 Anti-Inflammatory Drugs
2.6 Corticosteroids
2.7 Nonsteroidal Anti-inflammatory Drugs
2.8 Biologics
2.9 Others
3 Autoimmune Disease Therapeutics Market Overview by Application
3.1 Global Autoimmune Disease Therapeutics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2016-2021)
3.3 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Clinics
3.6 Independent Pharmacies
3.7 Others
4 Autoimmune Disease Therapeutics Competition Analysis by Players
4.1 Global Autoimmune Disease Therapeutics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2020)
4.3 Date of Key Players Enter into Autoimmune Disease Therapeutics Market
4.4 Global Top Players Autoimmune Disease Therapeutics Headquarters and Area Served
4.5 Key Players Autoimmune Disease Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Autoimmune Disease Therapeutics Products, Services and Solutions
5.1.4 Pfizer Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.1.5 Pfizer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Autoimmune Disease Therapeutics Products, Services and Solutions
5.2.4 Novartis Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.2.5 Novartis Recent Developments
5.3 Johnson & Johnson Services
5.3.1 Johnson & Johnson Services Profile
5.3.2 Johnson & Johnson Services Main Business
5.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Products, Services and Solutions
5.3.4 Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Autoimmune Disease Therapeutics Products, Services and Solutions
5.4.4 Merck Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.4.5 Merck Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Autoimmune Disease Therapeutics Products, Services and Solutions
5.5.4 Sanofi Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.5.5 Sanofi Recent Developments
5.6 Abott
5.6.1 Abott Profile
5.6.2 Abott Main Business
5.6.3 Abott Autoimmune Disease Therapeutics Products, Services and Solutions
5.6.4 Abott Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.6.5 Abott Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 Amgen
5.8.1 Amgen Profile
5.8.2 Amgen Main Business
5.8.3 Amgen Autoimmune Disease Therapeutics Products, Services and Solutions
5.8.4 Amgen Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.8.5 Amgen Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Autoimmune Disease Therapeutics Products, Services and Solutions
5.9.4 Bayer Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.9.5 Bayer Recent Developments
5.10 F. Hoffmann-La Roche
5.10.1 F. Hoffmann-La Roche Profile
5.10.2 F. Hoffmann-La Roche Main Business
5.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Products, Services and Solutions
5.10.4 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.10.5 F. Hoffmann-La Roche Recent Developments
5.11 Eli Lilly and Company
5.11.1 Eli Lilly and Company Profile
5.11.2 Eli Lilly and Company Main Business
5.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Products, Services and Solutions
5.11.4 Eli Lilly and Company Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.11.5 Eli Lilly and Company Recent Developments
6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Therapeutics Market Dynamics
11.1 Autoimmune Disease Therapeutics Industry Trends
11.2 Autoimmune Disease Therapeutics Market Drivers
11.3 Autoimmune Disease Therapeutics Market Challenges
11.4 Autoimmune Disease Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Autoimmune Disease Therapeutics Market Overview
1.1.1 Autoimmune Disease Therapeutics Product Scope
1.1.2 Autoimmune Disease Therapeutics Market Status and Outlook
1.2 Global Autoimmune Disease Therapeutics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Autoimmune Disease Therapeutics Market Size by Region (2016-2027)
1.4 Global Autoimmune Disease Therapeutics Historic Market Size by Region (2016-2021)
1.5 Global Autoimmune Disease Therapeutics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.1 North America Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.2 Europe Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.4 Latin America Autoimmune Disease Therapeutics Market Size (2016-2027)
1.6.5 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2016-2027)
2 Autoimmune Disease Therapeutics Market Overview by Type
2.1 Global Autoimmune Disease Therapeutics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2016-2021)
2.3 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2022-2027)
2.4 Immunosuppressants
2.5 Anti-Inflammatory Drugs
2.6 Corticosteroids
2.7 Nonsteroidal Anti-inflammatory Drugs
2.8 Biologics
2.9 Others
3 Autoimmune Disease Therapeutics Market Overview by Application
3.1 Global Autoimmune Disease Therapeutics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2016-2021)
3.3 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Clinics
3.6 Independent Pharmacies
3.7 Others
4 Autoimmune Disease Therapeutics Competition Analysis by Players
4.1 Global Autoimmune Disease Therapeutics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2020)
4.3 Date of Key Players Enter into Autoimmune Disease Therapeutics Market
4.4 Global Top Players Autoimmune Disease Therapeutics Headquarters and Area Served
4.5 Key Players Autoimmune Disease Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Autoimmune Disease Therapeutics Products, Services and Solutions
5.1.4 Pfizer Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.1.5 Pfizer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Autoimmune Disease Therapeutics Products, Services and Solutions
5.2.4 Novartis Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.2.5 Novartis Recent Developments
5.3 Johnson & Johnson Services
5.3.1 Johnson & Johnson Services Profile
5.3.2 Johnson & Johnson Services Main Business
5.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Products, Services and Solutions
5.3.4 Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Autoimmune Disease Therapeutics Products, Services and Solutions
5.4.4 Merck Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.4.5 Merck Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Autoimmune Disease Therapeutics Products, Services and Solutions
5.5.4 Sanofi Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.5.5 Sanofi Recent Developments
5.6 Abott
5.6.1 Abott Profile
5.6.2 Abott Main Business
5.6.3 Abott Autoimmune Disease Therapeutics Products, Services and Solutions
5.6.4 Abott Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.6.5 Abott Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 Amgen
5.8.1 Amgen Profile
5.8.2 Amgen Main Business
5.8.3 Amgen Autoimmune Disease Therapeutics Products, Services and Solutions
5.8.4 Amgen Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.8.5 Amgen Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Autoimmune Disease Therapeutics Products, Services and Solutions
5.9.4 Bayer Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.9.5 Bayer Recent Developments
5.10 F. Hoffmann-La Roche
5.10.1 F. Hoffmann-La Roche Profile
5.10.2 F. Hoffmann-La Roche Main Business
5.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Products, Services and Solutions
5.10.4 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.10.5 F. Hoffmann-La Roche Recent Developments
5.11 Eli Lilly and Company
5.11.1 Eli Lilly and Company Profile
5.11.2 Eli Lilly and Company Main Business
5.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Products, Services and Solutions
5.11.4 Eli Lilly and Company Autoimmune Disease Therapeutics Revenue (US$ Million) & (2016-2021)
5.11.5 Eli Lilly and Company Recent Developments
6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Therapeutics Market Dynamics
11.1 Autoimmune Disease Therapeutics Industry Trends
11.2 Autoimmune Disease Therapeutics Market Drivers
11.3 Autoimmune Disease Therapeutics Market Challenges
11.4 Autoimmune Disease Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
